U.S. flag

An official website of the United States government

NM_173543.3(DZIP1L):c.1825G>A (p.Gly609Arg) AND Polycystic kidney disease 5

Germline classification:
Uncertain significance (1 submission)
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003340657.2

Allele description [Variation Report for NM_173543.3(DZIP1L):c.1825G>A (p.Gly609Arg)]

NM_173543.3(DZIP1L):c.1825G>A (p.Gly609Arg)

Gene:
DZIP1L:DAZ interacting zinc finger protein 1 like [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3q22.3
Genomic location:
Preferred name:
NM_173543.3(DZIP1L):c.1825G>A (p.Gly609Arg)
HGVS:
  • NC_000003.12:g.138068158C>T
  • NM_173543.3:c.1825G>AMANE SELECT
  • NP_775814.2:p.Gly609Arg
  • NC_000003.11:g.137787000C>T
  • NM_173543.2:c.1825G>A
Protein change:
G609R
Molecular consequence:
  • NM_173543.3:c.1825G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Polycystic kidney disease 5
Identifiers:
MONDO: MONDO:0033281; MedGen: C4539903; OMIM: 617610

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004047315Neuberg Centre For Genomic Medicine, NCGM
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significancegermlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Neuberg Centre For Genomic Medicine, NCGM, SCV004047315.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The missense variant p.G609R in DZIP1L (NM_173543.3) has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.G609R variant is observed in 2/978 (0.2045%) alleles from individuals of South Asian background in 1000 Genomes, which is greater than expected for the disorder. There is a moderate physicochemical difference between glycine and arginine. In silico tools predict the variant to be tolerated. The residue is conserved across species. The amino acid change p.Gly609Arg in DZIP1L is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Uncertain Significance

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024